# Rigel Pharmaceuticals Inc: Form 8-K, filed Nov 15, 2021

- Company: [Rigel Pharmaceuticals Inc](/companies/rigl.md) (CIK 1034842)
- Form: 8-K
- Filed: 2021-11-15
- Accepted by EDGAR: Nov 15, 2021, 09:00 ET
- Period: 2021-11-12
- Accession: 0001104659-21-138665
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1034842/000110465921138665/tm2132728d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1034842/000110465921138665/

## Items reported

- Item 2.05: Exit or disposal costs

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1034842/000110465921138665/tm2132728d1_8k.htm

Filed Nov 15, 2021.
Source: SEC EDGAR, the filing index for accession 0001104659-21-138665. Last ingested by Listed: Nov 14, 2026, 23:09 ET. No prices; not investment advice.
